cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.25402/pmt.14805789
title: Supplementary data: Physical, Emotional and Social Pain Communication by Patients Diagnosed and Living with Multiple Myeloma

description: Supplementary
 Table 1: Definition of aspects of pain
 Supplementary Table 2: Thresholds for clinical importance
 for the EORTC QLQ-C30 scores
 <b>Supplementary Table 3: Health-related
 quality of life by multiple myeloma patient self-reported pain severity</b>
 <b> </b>
 <b>Supplementary Table 4: Level of
 agreement between symptoms reported by patients in self-reported symptoms
 list and EORTC-QLQ-MY20 (using Cohen's kappa analysis)</b>
 <b> </b>
 <b>Supplementary Table 6: Level of
 agreement between symptoms reported by patients and those recorded by the
 treating physician at their face-to-face clinical consultation (using Cohen's
 kappa analysis)</b>
 <b> </b>
 Physical,
 Emotional and Social Pain Communication by Patients Diagnosed and Living with
 Multiple Myeloma
 
 <b>ABSTRACT</b>
 <b> </b>
 <b>Background: </b> To
 describe physical, social, and emotional aspects of
 pain self-reported by patients with multiple myeloma (MM), and patient-physician communication of physical pain. 
 
 <b>Methods: </b>We analysed self-reported data
 from 330 adults receiving anti-MM therapy in Germany and Italy on
 health-related quality of life (EORTC QLQ-C30, -MY20) and bone pain symptoms.
 
 <b>Results: </b>Patients experienced clinically
 important physical (69%), emotional (58%) and social (22%) pain. Less than
 three-quarters of physicians’ records matched patients’ perception of bone
 pain (71.5%), with bone pain not recorded in 19.7% of patients experiencing
 it. Nearly half of physicians underestimated bone pain severity. 
 
 




<b>Conclusion: </b>Patients with MM experience
physical, social and emotional pain.<b> </b>Discordance
regarding bone pain symptoms and severity was observed, suggesting the need for
improved communication.
DOI: 10.25402/pmt.16437903
title: Supplementary data: The relationship between diet and relative risk of pain in a cross-sectional analysis of the REGARDS longitudinal study

description: Supplementary tables
describing the base characteristics of the 16061 participants from the REGARDS
cohort analysed in this study, and the relative risk of pain of each dietary
regimen according to the Modified Poisson Regression Analysis employed in the study.
DOI: 10.25402/pmt.16923919
title: Supplementary Tables S2.1 and S2.2: Patient-reported factors associated with degree of pain medication dependence and presence of severe dependence among spinal outpatients

description: <b>Abstract</b>
 Aims: To identify
 risk factors for pain medication dependence. 
 Methods: Chronic
 spinal pain outpatients (n=106) completed the Leeds Dependence. Questionnaire
 (LDQ) and measures of potential risk factors. Participants with high (n=3)
 and low (n=3) dependence were interviewed.
 Results: Mean LDQ
 score was 11.52 (SD 7.35) and 15/106 participants (14.2%) were severely
 dependent (LDQ ≥20). In linear regression, pain intensity (β=0.313,
 p&lt;0.001), being disabled by pain (β=0.355, p&lt;0.001), borrowing pain
 medication (β=0.209, p=0.006), and emergency phone calls or clinic visits
 (β=0.169, p=0.029) were associated with degree of dependence across the range
 of LDQ scores. In logistic regression, pain intensity (p=0.001) and borrowing
 pain medication (p=0.004) increased the odds of severe dependence.
 Interviewees described how their pain influenced their pain medication use
 and one described pain medication addiction.
 
 




Conclusions: Interventions to reduce pain
intensity and pain-related disability may reduce pain medication dependence.
DOI: 10.15468/dl.26krsz
title: Occurrence Download

description: A dataset containing 58 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Alpheus inopinatus Holthuis & Gottlieb, 1958"
 ]
}

 The dataset includes 58 records from 9 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0019914-240506114902167/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25402/pmt.16923922
title: Supplementary Table S1: Patient-reported factors associated with degree of pain medication dependence and presence of severe dependence among spinal outpatients

description: <b>Abstract</b>
 Aims: To identify
 risk factors for pain medication dependence. 
 Methods: Chronic
 spinal pain outpatients (n=106) completed the Leeds Dependence. Questionnaire
 (LDQ) and measures of potential risk factors. Participants with high (n=3)
 and low (n=3) dependence were interviewed.
 Results: Mean LDQ
 score was 11.52 (SD 7.35) and 15/106 participants (14.2%) were severely
 dependent (LDQ ≥20). In linear regression, pain intensity (β=0.313,
 p&lt;0.001), being disabled by pain (β=0.355, p&lt;0.001), borrowing pain
 medication (β=0.209, p=0.006), and emergency phone calls or clinic visits
 (β=0.169, p=0.029) were associated with degree of dependence across the range
 of LDQ scores. In logistic regression, pain intensity (p=0.001) and borrowing
 pain medication (p=0.004) increased the odds of severe dependence.
 Interviewees described how their pain influenced their pain medication use
 and one described pain medication addiction.
 
 




Conclusions: Interventions to reduce pain
intensity and pain-related disability may reduce pain medication dependence.
DOI: 10.25402/pmt.16988113
title: Supplementary data. The experience of participants with chronic pain in a pilot randomized clinical trial using a ketogenic diet

description: Trial participant
flow diagram, study timeline, diet questionnaire and responses.
DOI: 10.25402/pmt.17040284
title: Supplementary Table 2: Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase 3 safety study

description: <b>Supplementary
 Table 2</b>. Tanezumab for Chronic Low Back Pain: A Long-term, Randomized,
 Celecoxib-Controlled, Japanese, Phase 3, Safety Study<br>
 <i>Summary of
 all-causality TEAEs through week 80 (treatment + follow-up period)</i>
 <br>
DOI: 10.25402/pmt.17040287
title: Supplementary Table 4: Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase 3 safety study

description: <br>


 
 
 <b>Supplementary
 Table 4. </b>Tanezumab for Chronic Low Back Pain: A Long-term, Randomized,
 Celecoxib-Controlled, Japanese, Phase 3, Safety Study<b></b>
 <i>Summary of TEAEs of possible decreased
 sympathetic function through week 80 (treatment + follow-up periods)</i>
 
 


<br>
DOI: 10.25402/pmt.17040290
title: Supplementary Table 3: Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase 3 safety study

description: <br>
 


 
 
 <b>Supplementary
 Table 3</b>. Tanezumab for Chronic Low Back Pain: A Long-term, Randomized,
 Celecoxib-Controlled, Japanese, Phase 3, Safety Study
 <i>Summary of TEAEs
 of abnormal peripheral sensation through week 80 (treatment + follow-up
 periods)</i>
DOI: 10.25402/pmt.17040299
title: Supplementary Table 1: Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase 3 safety study

description: <b>Supplementary
 Table 1.</b> Tanezumab for Chronic Low Back Pain: A Long-term, Randomized,
 Celecoxib-Controlled, Japanese, Phase 3, Safety Study
 <i>Imputation of
 missing LBPI and RMDQ data</i>
 <br>
DOI: 10.15468/dl.nnxaga
title: Occurrence Download

description: A dataset containing 4117 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is one of (Sporobolus ×townsendii (H.Groves & J.Groves) P.M.Peterson & Saarela)"
 ]
}

 The dataset includes 4117 records from 115 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0019915-240506114902167/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25402/pmt.17161844
title: Supplementary data: Interoception and social cognition in chronic low back pain: a common inference disturbance? An exploratory study

description: Supplementary
materials
DOI: 10.5281/zenodo.11202665
title: Svalbox-DOM_2024-0014

description: Model description: Digital model of CavendishryggenData availability:All uploaded archives are to be extracted to the same directory for a functional working environment, i.e., at the very least consisting of a project folder with the data and metashape subdirectories. The included processing report specifies the processing parameters that were used as input for the processing software (Agisoft Metashape, v2.1.0.17532).Exported model data use CRS epsg:32633.Show and visualise on Svalbox.no:Through Svalbox we aim to take geoscientific research and education to the next level – with the simple motto of placing all key information and data sets in their correct spatial position. We bring modern technology, in particular cost-effective digital outcrops, to complement more than 200 years of geoscientific research on Svalbard. Finally, Svalbox provides a sustainable platform for sharing results, workflows and teaching material with the wider geoscientific community.For more information, contact the Svalbox team at svalbox[at]gmail.com.This data set forms part of the Svalbox Digital Model Database.Please cite the database alongside this resource:Betlem, Peter and Rodes, Nil and Birchall, Thomas and Dahlin, Anders and Smyrak-Sikora, Aleksandra and Senger, Kim. The Svalbox Digital Model Database: A Geoscientific Window into the High Arctic. Geosphere (2023) 19 (6): 1640-1666. https://doi.org/10.1130/GES02606.1
DOI: 10.5281/zenodo.11202666
title: Svalbox-DOM_2024-0014

description: Model description: Digital model of CavendishryggenData availability:All uploaded archives are to be extracted to the same directory for a functional working environment, i.e., at the very least consisting of a project folder with the data and metashape subdirectories. The included processing report specifies the processing parameters that were used as input for the processing software (Agisoft Metashape, v2.1.0.17532).Exported model data use CRS epsg:32633.Show and visualise on Svalbox.no:Through Svalbox we aim to take geoscientific research and education to the next level – with the simple motto of placing all key information and data sets in their correct spatial position. We bring modern technology, in particular cost-effective digital outcrops, to complement more than 200 years of geoscientific research on Svalbard. Finally, Svalbox provides a sustainable platform for sharing results, workflows and teaching material with the wider geoscientific community.For more information, contact the Svalbox team at svalbox[at]gmail.com.This data set forms part of the Svalbox Digital Model Database.Please cite the database alongside this resource:Betlem, Peter and Rodes, Nil and Birchall, Thomas and Dahlin, Anders and Smyrak-Sikora, Aleksandra and Senger, Kim. The Svalbox Digital Model Database: A Geoscientific Window into the High Arctic. Geosphere (2023) 19 (6): 1640-1666. https://doi.org/10.1130/GES02606.1
DOI: 10.25402/pmt.17161847
title: Supplementary Table S1: Atogepant and sumatriptan: no clinically relevant drug-drug interactions in a randomized, open-label, crossover trial

description: <b>Supplementary
 Table 1</b>. Atogepant and
 Sumatriptan: No Clinically Relevant Drug-Drug Interactions in a Randomized,
 Open-label, Crossover Trial
 
 
 




<i>Intervention Sequences</i>
DOI: 10.25402/pmt.19453739
title: Supplementary material – A randomized-controlled trial on the effect of Anaesthesia on Chronic Pain after Total Knee Arthroplasty

description: Table 2: Demographics of the study population, on an intention-to-treat analysis<br>
DOI: 10.25402/pmt.21130291
title: The relevance of real-world data for the evaluation of neuropathic pain treatments - Supplementary material

description:   
<strong>Supplementary table 1.</strong> Results of EudraCT clinical trial registry search
 <strong>Supplementary table 2.</strong> Results of ClinicalTrial.gov registry search
DOI: 10.25402/pmt.21261453
title: Pupillary reflex dilation and pain index evaluation during general anesthesia using sufentanil: a double-blind randomized controlled trial - Supplementary Material

description:  Supplementary table 1: baseline demographic data 
 Supplementary table 2: T0 measurement 
 Supplementary table 3: T1 measurement 
Supplementary table 4: T2 measurement
Supplementary table 5: perioperative   comparison
 Supplementary table 6: PPI 1/2 vs ≥ 3 in group compared
DOI: 10.25402/pmt.21828396
title: Modulation of mTORC1 & IL-6 following mirror therapy and Pregabalin in Complex Regional Pain Syndrome type 1 - Supplementary Material

description: Consort diagram 
<br>
  
<strong>Table 4(Supplementary): Pearson’s correlation between NRS pain score and delta Ct values of mRNA expression of IL-6 and mTORc1 genes in Group MT at the end of 12th week</strong>
  
<strong>Table 5(Supplementary): NPSI scores for “Burning sensation” in group CT and MT</strong>
  
<strong>Table 6(Supplementary): Neuropathic Pain Symptom Inventory scores for “Electric-shock” sensation in group CT and MT</strong>
  
<strong>Table 7(Supplementary): Neuropathic Pain Symptom Inventory scores for “Allodynia” in group CT and MT</strong>
  
<strong>Table 8(Supplementary): SF-12 QoL “Physical Component Summary” and “Mental Component Summary” scores at designated time intervals</strong>
<br>
DOI: 10.25402/pmt.21981674
title: Epidural dexamethasone for acute postoperative pain management: a systematic review with meta-analysis - supplementary material

description: PRISMA 2020 checklist
DOI: 10.25402/pmt.22811147
title: Low back pain management in routine clinical practice – what is important for the individual patient? - Supplementary material

description:   
<strong>Table 1. </strong>Study characteristics and patients’ baseline data
  
<strong>Table 2. </strong> Mean change from baseline to end of observation in pain intensity and pain-related aspects under tapentadol PR treatment and responder rates (NIT 1-3)
  
<strong>Table 3. </strong>Mean change from baseline to end of observation in pain intensity and daily functioning under tapentadol PR treatment and responder rates (NIT-4)
  
<strong>Table 4. </strong>Mean change from baseline to end of observation in daily functioning and quality of life under tapentadol PR
  
<strong>Table 5. </strong>Attainment of additional individual treatment goals with tapentadol PR, jointly chosen by physician and patient
  
<strong>Table 6. </strong>Questionnaire used for the online patient research survey
  
<strong>Table 7. </strong>SF-12 domains included in the principal questionnaire used for the online patient research survey versus the original SF-12 domains
  
<strong>Table 8. </strong>Sociodemographic characteristics of the survey respondents (N = 300)
  
<strong>Figure 1. </strong>The most important goals of chronic back pain therapy (online patient research survey question 1 ‘important treatment goal’ [unprompted]).
  
<strong>Table 9. </strong>Online patient research survey - Importance of individual top-3 SF-12 domains and other additional aspects by age, pain intensity, and gender
<br>
DOI: 10.25402/pmt.23091071
title: Access to cancer pain management in Ecuador from health workers' perspective: a qualitative study. Supplementary data.

description: Supplementary data files 1 and 2
DOI: 10.25402/pmt.23652423
title: User experiences of pre-sleep sensory alpha brainwave entrainment for people with chronic pain and sleep disturbance.

description: hBET template V5.1
DOI: 10.25402/pmt.23652423.v1
title: User experiences of pre-sleep sensory alpha brainwave entrainment for people with chronic pain and sleep disturbance.

description: hBET template V5.1
DOI: 10.25402/epi.16616218.v1
title: epi-2021-0168 Suppl. Table 1

description: <b>Table. S1.</b> <b>List of the samples used in this study.</b>
DOI: 10.25402/pmt.23931507
title: Review of racial/ethnic disparities in obstetrics-related anesthesia administration and pain management

description: we present a summary of key studies that address different facets of racial/ethnic disparities in obstetric anesthesia care (Supplementary Table 1).
DOI: 10.25402/pmt.23931507.v1
title: Review of racial/ethnic disparities in obstetrics-related anesthesia administration and pain management

description: we present a summary of key studies that address different facets of racial/ethnic disparities in obstetric anesthesia care (Supplementary Table 1).
DOI: 10.25402/pmt.24336352
title: Simultaneous application of lidocaine and ketamine during ambulatory infusion therapy: a retrospective analysis

description: monitoring sheet
DOI: 10.25402/pmt.24336352.v1
title: Simultaneous application of lidocaine and ketamine during ambulatory infusion therapy: a retrospective analysis

description: monitoring sheet
DOI: 10.25402/pmt.24433456
title: The impact of intraoperative N-acetylcysteine on opioid consumption following spine surgery: a randomized pilot trial

description: suppl data
DOI: 10.25402/pmt.24433456.v1
title: The impact of intraoperative N-acetylcysteine on opioid consumption following spine surgery: a randomized pilot trial

description: suppl data
DOI: 10.25402/pmt.24523783
title: Peripheral nerve stimulation for chronic knee pain following total knee arthroplasty: a systematic review

description: appendix 1 and 2
DOI: 10.25402/pmt.24523783.v1
title: Peripheral nerve stimulation for chronic knee pain following total knee arthroplasty: a systematic review

description: appendix 1 and 2
DOI: 10.25402/pmt.25151432
title: Pain management for post-treatment survivors of complex cancers: a qualitative study of opioids and cannabis

description: Suppl data
DOI: 10.25402/pmt.25151432.v1
title: Pain management for post-treatment survivors of complex cancers: a qualitative study of opioids and cannabis

description: Suppl data
DOI: 10.15468/dl.9xhxj3
title: Occurrence Download

description: A dataset containing 801 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Penaeus vannamei Boone, 1931"
 ]
}

 The dataset includes 801 records from 40 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0019916-240506114902167/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25402/rme.14884206
title: Supplementary Table 1: LncRNA Xist promotes osteoclast differentiation through Tgif2 by acting as a ceRNA of miR-590-3p in a murine model

description: Supplementary Table 1: Primer sequence for qRT-PCR <br>
DOI: 10.15468/dl.9smhmk
title: Occurrence Download

description: A dataset containing 5698 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is one of (Sporobolus vaginiflorus (Torr. ex A.Gray) Alph.Wood)"
 ]
}

 The dataset includes 5698 records from 232 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0019917-240506114902167/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25402/epi.16810408.v1
title: EPI-2021-0133 Suppl. Data

description: Supplementary Table
 1. Primers used for COBRA, RT- and Copy Number- qPCRs.
 Supplementary
 table 2: List of Log2 fold-change values of genes in Tet/Tet neurons and
 their corresponding values described by CommonMind Consortium (CMC),
 PsychENCODE and Brain Seq.
 Supplementary
 Table 3: Gene ontology and pathway enrichment analysis of 1135 dysregulated
 genes in Tet/Tet neurons
 Supplementary
 Table 4: Disease ontology of 1135 dysregulated genes in Tet/Tet neurons.
 Supplementary
 Table 5: List of Log2 fold-change values of genes in Tet/Tet ESCs and their
 corresponding values described by CommonMind Consortium (CMC), PsychENCODE
 and Brain Seq.
 Supplementary
 Table 6: Gene ontology and pathway enrichment analysis of 170 dysregulated
 genes in Tet/Tet ESCs.
 
 




Supplementary Table 7: Disease ontology of 170
dysregulated genes in 


 
 
 Tet/Tet ESCs.
 Supplementary
 Table 8: List of Log2 fold-change values of genes in Tet/Tet ESCs, Tet/Tet
 neurons and their corresponding values described by CommonMind Consortium
 (CMC), PsychENCODE and Brain Seq.
 Supplementary
 Table 9. List of imprinted genes showing dysregulation and hypomethylation in
 Tet/Tet neurons. Imprinted genes associated with Schizophrenia are shown in
 red.
 Supplementary
 Table 10. Analysis of methylation of repeat elements in Tet/Tet ESCs. Total
 reads (hypermethylated + hypomethylated) less than 20 were not considered.
 
 




Supplementary Figure 1: COBRA assay of Snrpn,
H19, Igf2r, IAP and LINE-1 elements. -: no enzyme control; +: reactions
incubated with with Taqα1 (H19 and LINE-1) or HpyCH4IV (Snrpn, Igf2r and IAP).
Presence of digested fragments indicates methylation. M- Marker
DOI: 10.25402/rme.14884245
title: Supplementary table: Mechanisms underlying the therapeutic potential of mesenchymal stem cells in atherosclerosis

description: Supplementary Table 1. A table summarising the key studies cited in the review. MSC = Mesenchymal Stem Cell; A-MSCs = Adipose-derived mesenchymal stem cells; BM-MSCs= Bone marrow-derived MSCs; ELC = Endothelial-like cell; PPARα = Peroxisome proliferator-activated receptor-alpha.
DOI: 10.25402/epi.16843240.v1
title: Per- and Polyfluoroalkyl Substances (PFAS), Epigenetic Age, and DNA Methylation: A Cross-Sectional Study of Firefighters

description: <b>Supplemental Table S1. Serum PFAS Concentrations
 (geometric means, ng/mL) by Categorical Demographic Variables</b>
 <b>Supplemental
 Table S2. Significantly Differentially Methylated CpG Sites by PFAS Seum
 Concentration (at q-value&lt;0.2)</b>
 <b>Supplemental Table S3. Significantly Differentially Methylated
 Regions by PFAS Exposure</b>
 <b>Supplemental Table S4. Pathways Enriched for Differential
 Methylation by PFAS Exposure</b>
 <b>Supplemental Table S5. Association between Serum PFAS
 Concentrations (ln-transformed ng/mL) and Cell Type Estimates</b>
DOI: 10.25402/rme.15090144
title: Supplementary Table 1: Urine-based regenerative RNA biomarkers for urinary bladder wound healing

description: <b>Supplement Table 1.</b>
 The expression of genes in morning and evening<br>
 
 <b>Abstract</b>
 
 




<b>Background:</b> This study aimed to investigate the expression of regeneration-related
genes in canine urine during bladder repair. <b>Materials & methods:</b>
Canine urine samples were collected after partial cystectomy. Regenerative mRNA
of hypoxia-inducible factor (HIF), vascular endothelial growth factor (VEGF),
key stem cell transcription factors, and cholinergic signals were detected. <b>Results:</b>
HIF-1α, VEGF, CD44, interleukin-6, and prominin 1 expression in canine urine
after partial cystectomy exhibited two similar peaks at ~2 weeks. HIF-1α and
VEGF expression was higher in the afternoon than in the morning. The expression
of key stem cell transcription factors and cholinergic signals also exhibited a
rhythm along with bladder healing. <b>Conclusions:</b> The expression of
HIF-1α, VEGF, key stem cell transcription factors, and cholinergic signals
exhibited a time curve distribution during canine bladder healing. The
expression trend of some regenerative genes was similar during bladder healing,
and a cooperative effect may exist.